4//SEC Filing
MacKenzie Lloyd 4
Accession 0001209191-18-020680
CIK 0001404644other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:58 PM ET
Size
12.9 KB
Accession
0001209191-18-020680
Insider Transaction Report
Form 4
MacKenzie Lloyd
VP Technical Operations
Transactions
- Exercise/Conversion
Common Stock
2018-03-15$10.56/sh+1,302$13,749→ 1,302 total - Sale
Common Stock
2018-03-15$14.63/sh−1,302$19,049→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-03-15−1,302→ 0 totalExercise: $10.56Exp: 2018-04-23→ Common Stock (1,302 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.62 to $14.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set in this footnote.
- [F2]All shares subject to the 1,302 share option were fully vested on 3/31/2012.
Issuer
AQUINOX PHARMACEUTICALS, INC
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001600164
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:58 PM ET
- Size
- 12.9 KB